Clinically Significant Dysregulation of hsa-miR-30d-5p and hsa-let-7b Expression in Patients with Surgically Resected Non-Small Cell Lung Cancer.
about
Clinically Significant Dysregulation of hsa-miR-30d-5p and hsa-let-7b Expression in Patients with Surgically Resected Non-Small Cell Lung Cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Clinically Significant Dysregu ...... ed Non-Small Cell Lung Cancer.
@en
Clinically Significant Dysregu ...... ed Non-Small Cell Lung Cancer.
@nl
type
label
Clinically Significant Dysregu ...... ed Non-Small Cell Lung Cancer.
@en
Clinically Significant Dysregu ...... ed Non-Small Cell Lung Cancer.
@nl
prefLabel
Clinically Significant Dysregu ...... ed Non-Small Cell Lung Cancer.
@en
Clinically Significant Dysregu ...... ed Non-Small Cell Lung Cancer.
@nl
P2093
P2860
P1476
Clinically Significant Dysregu ...... ed Non-Small Cell Lung Cancer.
@en
P2093
Abouzar Bagheri
Bahram Mohammad Soltani
Elham Tafsiri
Hamid Reza Khorram Khorshid
Mahmoud Tavallaei
Sayed Mostafa Hosseini
Seyed Javad Mowla
P2860
P304
P577
2018-04-01T00:00:00Z